Search
Caplacizumab
go.drugbank.com/drugs/DB06081ApprovedInvestigationalCaplacizumab was developed by Ablynx, a Sanofi company and FDA approved on February 6, 2019,[L5302] and approved previously by the EU in October 2018 as a combination therapy with plasma exchange and immunosuppression … Caplacizumab, firstly called ALX-0081, is a humanized single-variable-domain immunoglobulin consisting of two identical humanized building blocks genetically linked by a three-alanine linker.
Products: CABLIVI®, Cablivi 10 mg/1 mL Enjeksiyonluk Çözelti Hazırlamak İçin Toz ve Çözücü, 1 ADETCardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-15:0/a-21:0)
smpdb.ca/view/SMP0043362DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-17:0/a-15:0)
smpdb.ca/view/SMP0043378DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-17:0/a-21:0)
smpdb.ca/view/SMP0043380DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-25:0/a-21:0)
smpdb.ca/view/SMP0043415DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/18:2(9Z,11Z)/a-13:0)
smpdb.ca/view/SMP0043645DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/18:2(9Z,11Z)/a-17:0)
smpdb.ca/view/SMP0043647DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/a-15:0/18:2(9Z,11Z))
smpdb.ca/view/SMP0043680DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/a-17:0/18:2(9Z,11Z))
smpdb.ca/view/SMP0043697DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-15:0/18:2(9Z,11Z)/a-25:0)
smpdb.ca/view/SMP0043972DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.